This company has been acquired
Salud financiera de hoja de balance de Pardes Biosciences
Salud financiera controles de criterios 6/6
Pardes Biosciences has a total shareholder equity of $155.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $157.3M and $1.9M respectively.
Información clave
0%
Ratio deuda-patrimonio
US$0
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | US$153.20m |
| Patrimonio | US$155.39m |
| Total pasivo | US$1.93m |
| Activos totales | US$157.31m |
Actualizaciones recientes sobre salud financiera
We're Keeping An Eye On Pardes Biosciences' (NASDAQ:PRDS) Cash Burn Rate
Jul 18
Here's Why We're Watching Pardes Biosciences' (NASDAQ:PRDS) Cash Burn Situation
Jan 20We Think Pardes Biosciences (NASDAQ:PRDS) Needs To Drive Business Growth Carefully
Oct 01Pardes Biosciences (NASDAQ:PRDS) Is In A Good Position To Deliver On Growth Plans
Jun 14Recent updates
We're Keeping An Eye On Pardes Biosciences' (NASDAQ:PRDS) Cash Burn Rate
Jul 18Here's Why We're Watching Pardes Biosciences' (NASDAQ:PRDS) Cash Burn Situation
Jan 20We Think Pardes Biosciences (NASDAQ:PRDS) Needs To Drive Business Growth Carefully
Oct 01Pardes begins phase 2 trial of oral drug PBI-0451 for COVID-19
Sep 13Pardes Biosciences GAAP EPS of -$0.48
Aug 15Pardes Biosciences (NASDAQ:PRDS) Is In A Good Position To Deliver On Growth Plans
Jun 14Pardes Biosciences: Advancing A Viral Protease Inhibitor Platform
Jan 21Análisis de la situación financiera
Pasivos a corto plazo: PRDS's short term assets ($157.3M) exceed its short term liabilities ($1.9M).
Pasivo a largo plazo: PRDS has no long term liabilities.
Historial y análisis de deuda-patrimonio
Nivel de deuda: PRDS is debt free.
Reducción de la deuda: PRDS has not had any debt for past 5 years.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: PRDS has sufficient cash runway for more than a year based on its current free cash flow.
Pronóstico de cash runway: PRDS has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 75.6% each year.